EPIZYME INC's ticker is EPZM and the CUSIP is 29428V104. A total of 105 filers reported holding EPIZYME INC in Q3 2018. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2022 | $67,000 | -94.8% | 45,316 | -95.9% | 0.00% | -100.0% |
| Q1 2022 | $1,283,000 | -49.8% | 1,115,516 | +9.1% | 0.00% | -20.0% |
| Q4 2021 | $2,557,000 | +4091.8% | 1,022,627 | +8421.9% | 0.01% | – |
| Q3 2021 | $61,000 | -98.0% | 12,000 | -96.6% | 0.00% | -100.0% |
| Q1 2021 | $3,107,000 | +262.1% | 356,702 | +396.0% | 0.01% | +166.7% |
| Q3 2020 | $858,000 | -5.8% | 71,909 | +26.8% | 0.00% | -40.0% |
| Q2 2020 | $911,000 | -17.6% | 56,728 | -20.4% | 0.01% | -44.4% |
| Q1 2020 | $1,105,000 | +229.9% | 71,224 | +119.5% | 0.01% | +800.0% |
| Q3 2019 | $335,000 | -29.6% | 32,454 | -14.4% | 0.00% | -50.0% |
| Q2 2019 | $476,000 | -42.4% | 37,933 | -43.2% | 0.00% | -33.3% |
| Q1 2019 | $827,000 | -50.3% | 66,764 | -75.3% | 0.00% | -57.1% |
| Q4 2018 | $1,665,000 | +274.2% | 270,213 | +543.0% | 0.01% | +600.0% |
| Q3 2018 | $445,000 | +179.9% | 42,021 | +258.0% | 0.00% | – |
| Q2 2018 | $159,000 | – | 11,737 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RP Management, LLC | 9,166,667 | $109,358,000 | 16.39% |
| Burrage Capital Management LLC | 1,002,528 | $11,960,000 | 9.44% |
| Foresite Capital Management III, LLC | 998,278 | $11,909,000 | 8.87% |
| MPM BioImpact LLC | 2,854,737 | $34,057,000 | 8.20% |
| Palo Alto Investors LP | 6,403,600 | $76,395,000 | 4.19% |
| Foresite Capital Management II, LLC | 862,402 | $10,288,000 | 2.24% |
| Redmile Group, LLC | 8,311,633 | $99,158,000 | 1.82% |
| Pier Capital, LLC | 574,299 | $6,851,000 | 1.00% |
| Foresite Capital Management I, LLC | 243,759 | $2,908,000 | 0.82% |
| Rock Springs Capital Management LP | 2,551,659 | $30,441,000 | 0.77% |